LETTER TO THE EDITOR |
Trevor Duke, MBBS, MD, FRACP
Centre for International Child Health
Department of Paediatrics
University of Melbourne
Parkville, Victoria 3052, Australia
| The first 20% of the full text of this article appears below. |
To the Editor.
Recently, Blackmon et al1 reviewed the current evidence for the effectiveness and safety of hypothermia in newborns with hypoxic-ischemic encephalopathy (HIE). They urged caution in the interpretation of recently published randomized, controlled trials and argued that ongoing controlled trials of hypothermia should be completed. However, is it ethical for these trials to continue?
All 3 trials of mild systemic hypothermia for infants with HIE showed a substantial reduction in the
This article has been cited by other articles:
![]() |
P. S. Shah, A. Ohlsson, and M. Perlman Hypothermia to Treat Neonatal Hypoxic Ischemic Encephalopathy: Systematic Review Arch Pediatr Adolesc Med, October 1, 2007; 161(10): 951 - 958. [Abstract] [Full Text] [PDF] |
||||